US Stock MarketDetailed Quotes
TNON Tenon Medical
- 0.752
- +0.022+2.95%
Close Apr 26 16:00 ET
2.80MMarket Cap-87P/E (TTM)
0.760High0.710Low28.68KVolume0.750Open0.730Pre Close21.02KTurnover0.86%Turnover RatioLossP/E (Static)3.73MShares20.40052wk High3.60P/B2.52MFloat Cap0.71052wk Low--Dividend TTM3.35MShs Float598.900Historical High--Div YieldTTM6.84%Amplitude0.710Historical Low0.732Avg Price1Lot Size
Tenon Medical Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | (Q1)Mar 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -1.31%-12.18M | 32.70%-2.28M | 7.62%-3.15M | -14.95%-3.18M | -45.13%-3.58M | -180.17%-12.03M | -100.30%-3.39M | -141.89%-3.41M | -168.77%-2.76M | -1,411.66%-2.46M |
| Net income from continuing operations | 17.63%-15.58M | 60.35%-3.13M | -5.08%-3.33M | 21.92%-4.29M | -105.27%-4.83M | -167.15%-18.92M | -178.15%-7.91M | -34.19%-3.17M | -227.64%-5.49M | -1,070.65%-2.35M |
| Depreciation and amortization | 47.40%426K | 91.14%151K | 33.33%104K | 28.17%91K | 31.15%80K | 153.51%289K | 54.90%79K | 52.94%78K | 491.67%71K | --61K |
| Other non cash items | ---- | ---- | ---- | ---- | ---- | 4.06%1.92M | --0 | --0 | 274.77%1.65M | 2,183.33%274K |
| Change In working capital | -168.12%-1.17M | -108.62%-276K | 24.45%-995K | -107.95%-36K | 121.79%134K | 280.97%1.72M | 1,228.22%3.2M | -2,494.55%-1.32M | 240.60%453K | -2,773.91%-615K |
| -Change in receivables | -90.79%-290K | 403.57%255K | -149.28%-172K | -2,750.00%-285K | -900.00%-88K | -149.18%-152K | -1,580.00%-84K | -21.05%-69K | -200.00%-10K | 222.22%11K |
| -Change in inventory | 38.77%-139K | -120.25%-80K | 152.75%96K | -492.31%-154K | 99.76%-1K | -56.55%-227K | 337.95%395K | -18,300.00%-182K | -388.89%-26K | -3,863.64%-414K |
| -Change in prepaid assets | -428.07%-301K | -202.33%-44K | 278.95%68K | -243.28%-230K | -2,000.00%-95K | 56.15%-57K | 4,400.00%43K | -311.11%-38K | 54.42%-67K | --5K |
| -Change in payables and accrued expense | -109.15%-216K | -112.00%-348K | 5.02%-928K | 13.72%688K | 320.12%372K | 171.26%2.36M | 530.65%2.9M | -1,030.48%-977K | 113.03%605K | -904.76%-169K |
| -Change in other current liabilities | -12.38%-227K | -9.26%-59K | -15.69%-59K | -12.24%-55K | -12.50%-54K | -146.34%-202K | -14.89%-54K | -325.00%-51K | -113.04%-49K | ---48K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -1.31%-12.18M | 32.70%-2.28M | 7.62%-3.15M | -14.95%-3.18M | -45.13%-3.58M | -180.17%-12.03M | -100.30%-3.39M | -141.89%-3.41M | -168.51%-2.76M | -1,420.99%-2.46M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 312.97%6.14M | -103.93%-92K | 133.11%436K | 113.80%1.13M | 9.19%4.67M | 35.97%-2.88M | -30.70%2.34M | 83.28%-1.32M | -8.18M | 4.28M |
| Net PPE purchase and sale | 57.38%-361K | 84.69%-92K | 25.97%-57K | -212.20%-128K | 34.38%-84K | -730.39%-847K | -615.48%-601K | -327.78%-77K | ---41K | ---128K |
| Net investment purchase and sale | 419.24%6.5M | --0 | 139.76%493K | 115.44%1.26M | 7.92%4.75M | 53.73%-2.04M | -15.00%2.94M | 84.23%-1.24M | ---8.14M | --4.4M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 312.97%6.14M | -103.93%-92K | 133.11%436K | 113.80%1.13M | 9.19%4.67M | 35.97%-2.88M | -30.70%2.34M | 83.28%-1.32M | ---8.18M | --4.28M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -55.35%6.3M | 5,584.00%1.37M | 266K | -66.84%4.71M | 22.22%-42K | 23.06%14.11M | 86.03%-25K | 0 | 79.84%14.19M | -80.00%-54K |
| Net issuance payments of debt | --1.25M | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Net common stock issuance | -62.49%5.3M | --42K | --453K | ---- | ---- | --14.14M | --0 | --0 | ---- | ---- |
| Proceeds from stock option exercised by employees | --258K | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Net other financing activities | -1,936.00%-509K | ---179K | ---187K | ---101K | 22.22%-42K | 93.02%-25K | ---- | ---- | ---- | -80.00%-54K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -55.35%6.3M | 5,584.00%1.37M | --266K | -66.84%4.71M | 22.22%-42K | 23.06%14.11M | 86.03%-25K | --0 | 79.84%14.19M | -80.00%-54K |
| Net cash flow | ||||||||||
| Beginning cash position | -27.01%2.13M | 6.91%3.37M | -25.69%5.85M | -32.03%3.18M | -27.01%2.13M | 1,085.77%2.92M | 123.78%3.15M | 13.93%7.88M | 9,070.59%4.68M | 1,090.61%2.92M |
| Current changes in cash | 132.83%261K | 6.72%-999K | 48.18%-2.45M | -18.10%2.66M | -40.22%1.05M | -129.74%-795K | -171.16%-1.07M | 14.05%-4.73M | -52.67%3.25M | 1,015.63%1.76M |
| Effect of exchange rate changes | 442.86%38K | 19.15%56K | -475.00%-30K | 126.00%13K | -150.00%-1K | 450.00%7K | 2,250.00%47K | --8K | -2,400.00%-50K | 200.00%2K |
| End cash Position | 14.04%2.43M | 14.04%2.43M | 6.91%3.37M | -25.69%5.85M | -32.03%3.18M | -27.01%2.13M | -27.01%2.13M | 123.78%3.15M | 13.93%7.88M | 9,070.59%4.68M |
| Free cash flow | 2.55%-12.54M | 40.54%-2.37M | 8.02%-3.21M | -17.83%-3.3M | -41.20%-3.66M | -192.94%-12.87M | -124.69%-3.99M | -144.23%-3.49M | -172.50%-2.8M | -1,500.00%-2.59M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg